Huntingtin promotes cell survival by preventing Pak2 cleavage

Journal of Cell Science

Volumn 122, Issue 6, 2009, Pages 875-885

  Luo, Shouqing ^a   Rubinsztein, David C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Caspase; Huntingtin; Pak2; TNF

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIGEN; HUNTINGTIN; P21 ACTIVATED KINASE 2; TUMOR NECROSIS FACTOR ALPHA; MUTANT PROTEIN; NERVE PROTEIN; P21 ACTIVATED KINASE; PAK2 PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; MICE; MUTANT PROTEINS; NERVE TISSUE PROTEINS; P21-ACTIVATED KINASES; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66949178049     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.050013     Document Type: Article

References (47)

1. Abo, A., Qu, J., Cammarano, M. S., Dan, C., Fritsch, A., Baud, V., Belisle, B. and Minden, A. (1998). PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J. 17, 6527-6540.
2. Bagrodia, S., Taylor, S. J., Creasy, C. L., Chernoff, J. and Cerione, R. A. (1995). Identification of a mouse p21Cdc42/Rac activated kinase. J. Biol. Chem. 270, 22731-22737.
3. Beg, A. A. and Baltimore, D. (1996). An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782-784.
4. Bokoch, G. M. (2003). Biology of the p21-activated kinases. Annu. Rev. Biochem. 72, 743-781.
5. Cattaneo, E., Zuccato, C. and Tartari, M. (2005). Normal huntingtin function: an alternative approach to Huntington's disease. Nat. Rev. Neurosci. 6, 919-930.
6. Cau, J., Faure, S., Comps, M., Delsert, C. and Morin, N. (2001). A novel p21-activated kinase binds the actin and microtubule networks and induces microtubule stabilization. J. Cell Biol. 155, 1029-1042.
7. Chan, W. H., Yu, J. S. and Yang, S. D. (1998). Heat shock stress induces cleavage and activation of PAK2 in apoptotic cells. J. Protein Chem. 17, 485-494.
8. Cotteret, S., Jaffer, Z. M., Beeser, A. and Chernoff, J. (2003). p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol. Cell. Biol. 23, 5526-5539.
9. Dan, C., Nath, N., Liberto, M. and Minden, A. (2002). PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol. Cell. Biol. 22, 567-577.
10. Duval, D., Malaise, M., Reinhardt, B., Kedinger, C. and Boeuf, H. (2004). A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death Differ. 11, 331-341.
11. Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J. P., Gusella, J. F., Joyner, A. L. et al. (1995). Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269, 407-410.
12. Fischer, U., Stroh, C. and Schulze-Osthoff, K. (2006). Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene 25, 152-159.
13. Ho, L. W., Brown, R., Maxwell, M., Wyttenbach, A. and Rubinsztein, D. C. (2001). Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease. J. Med. Genet. 38, 450-452.
14. Hodgson, J. G., Agopyan, N., Gutekunst, C. A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J. et al. (1999). A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23, 181-192.
15. Hofmann, C., Shepelev, M. and Chernoff, J. (2004). The genetics of Pak. J. Cell Sci. 117, 4343-4354.
16. Hsu, H., Shu, H. B., Pan, M. G. and Goeddel, D. V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
17. Jaffer, Z. M. and Chernoff, J. (2002). p21-activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 34, 713-717.
18. Jakobi, R., Moertl, E. and Koeppel, M. A. (2001). p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J. Biol. Chem. 276, 16624-16634.
19. Jakobi, R., McCarthy, C. C., Koeppel, M. A. and Stringer, D. K. (2003). Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation. J. Biol. Chem. 278, 38675-38685.
20. Janicke, R. U., Sprengart, M. L., Wati, M. R. and Porter, A. G. (1998). Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360.
21. Kurokawa, H., Nishio, K., Fukumoto, H., Tomonari, A., Suzuki, T. and Saijo, N. (1999). Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol. Rep. 6, 33-37.
22. Leavitt, B. R., Guttman, J. A., Hodgson, J. G., Kimel, G. H., Singaraja, R., Vogl, A. W. and Hayden, M. R. (2001). Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am. J. Hum. Genet. 68, 313-324.
23. Luo, S., Vacher, C., Davies, J. E. and Rubinsztein, D. C. (2005). Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J. Cell Biol. 169, 647-656.
24. Luo, S., Mizuta, H. and Rubinsztein, D. C. (2008). p21-activated kinase 1 promotes soluble mutant huntingtin self-interaction and enhances toxicity. Hum. Mol. Genet. 17, 895-905.
25. Maglione, V., Cannella, M., Gradini, R., Cislaghi, G. and Squitieri, F. (2006). Huntingtin fragmentation and increased caspase 3, 8 and 9 activities in lymphoblasts with heterozygous and homozygous Huntington's disease mutation. Mech. Ageing Dev. 127, 213-216.
26. Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S. and Lim, L. (1994). A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40-46.
27. Manser, E., Chong, C., Zhao, Z. S., Leung, T., Michael, G., Hall, C. and Lim, L. (1995). Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J. Biol. Chem. 270, 25070-25078.
28. Manser, E., Huang, H. Y., Loo, T. H., Chen, X. Q., Dong, J. M., Leung, T. and Lim, L. (1997). Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol. Cell. Biol. 17, 1129-1143.
29. Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G. and Hayden, M. R. (1995). Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811-823.
30. Pandey, A., Dan, I., Kristiansen, T. Z., Watanabe, N. M., Voldby, J., Kajikawa, E., Khosravi-Far, R., Blagoev, B. and Mann, M. (2002). Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene 21, 3939-3948.
31. Qu, J., Li, X., Novitch, B. G., Zheng, Y., Kohn, M., Xie, J. M., Kozinn, S., Bronson, R., Beg, A. A. and Minden, A. (2003). PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol. Cell. Biol. 23, 7122-7133.
32. Rigamonti, D., Bauer, J. H., De-Fraja, C., Conti, L., Sipione, S., Sciorati, C., Clementi, E., Hackam, A., Hayden, M. R., Li, Y. et al. (2000). Wild-type huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. 20, 3705-3713.
33. Rigamonti, D., Sipione, S., Goffredo, D., Zuccato, C., Fossale, E. and Cattaneo, E. (2001). Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. J. Biol. Chem. 276, 14545-14548.
34. Rubinsztein, D. C. (2003). How does the Huntington's disease mutation damage cells? Sci. Aging Knowledge Environ. 2003, PE26.
35. Rubinsztein, D. C., Leggo, J., Coles, R., Almqvist, E., Biancalana, V., Cassiman, J. J., Chotai, K., Connarty, M., Crauford, D., Curtis, A. et al. (1996). Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet. 59, 16-22.
36. Rudel, T. and Bokoch, G. M. (1997). Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574.
37. Rudel, T., Zenke, F. T., Chuang, T. H. and Bokoch, G. M. (1998). p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J. Immunol. 160, 7-11.
38. Schurmann, A., Mooney, A. F., Sanders, L. C., Sells, M. A., Wang, H. G., Reed, J. C. and Bokoch, G. M. (2000). p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol. Cell. Biol. 20, 453-461.
39. Tang, T. K., Chang, W. C., Chan, W. H., Yang, S. D., Ni, M. H. and Yu, J. S. (1998). Proteolytic cleavage and activation of PAK2 during UV irradiation-induced apoptosis in A431 cells. J. Cell Biochem. 70, 442-454.
40. Teo, M., Manser, E. and Lim, L. (1995). Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J. Biol. Chem. 270, 26690-26697.
41. Trottier, Y., Devys, D., Imbert, G., Saudou, F., An, I., Lutz, Y., Weber, C., Agid, Y., Hirsch, E. C. and Mandel, J. L. (1995). Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat. Genet. 10, 104-110.
42. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M. (1996). Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789.
43. Wang, C. Y., Mayo, M. W. and Baldwin, A. S., Jr (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787.
44. Wellington, C. L., Ellerby, L. M., Gutekunst, C. A., Rogers, D., Warby, S., Graham, R. K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y. Z. et al. (2002). Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 7862-7872.
45. Yang, F., Li, X., Sharma, M., Zarnegar, M., Lim, B. and Sun, Z. (2001). Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6. J. Biol. Chem. 276, 15345-15353.
46. Zeitlin, S., Liu, J. P., Chapman, D. L., Papaioannou, V. E. and Efstratiadis, A. (1995). Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11, 155-163.
47. Zhang, Y., Leavitt, B. R., van Raamsdonk, J. M., Dragatsis, I., Goldowitz, D., Macdonald, M. E., Hayden, M. R. and Friedlander, R. M. (2006). Huntingtin inhibits caspase-3 activation. EMBO J. 25, 5896-5906.